Avi Ben-Abraham

Dr Avi Ben-Abraham is an American scientist who was involved in research work in the fields of low temperature medicine, cryogenics, and human and stem cell cloning.

Dr. Ben-Abraham is the founder and former chairman and chief executive officer of Biosante Pharmaceuticals Inc., (formerly Ben-Abraham Technologies inc.) a publicly traded American biotechnology company, developing its proprietary calcium phosphate nanotechnology (CaP) for vaccine adjuvants and delivery technology for biodefense vaccines. The company signed a CRADA with the U.S. Army for the development of non-injected biodefense vaccines against anthrax, ricin and staph. The company which makes a component of the 'Merrill Lynch Nanotech Index'-NNZ, was also awarded a subcontract for the development of a non-injected anthrax vaccine for the U.S. Department of Defense. In 1999, endorsed by Israel's Prime Minister Benjamin Netanyahu, Dr. Ben-Abraham won the primaries for a top seat on the governing Likud party list of candidates for the Knesset,^[1][2] but was not elected as Likud and Netanyahu were defeated by Labor party leader, former Israeli Defense Forces chief of staff Lt. General Ehud Barak.

References

1. ^ http://www.metroactive.com/papers/metro/05.13.99/public-eye-9919.html
2. ^ http://info.jpost.com/1999/Supplements/Elections99/politicalblocs/partylists.shtml

Persondata
Name
Alternative names
Short description
Date of birth
Place of birth
Date of death
Place of death